137 related articles for article (PubMed ID: 15932674)
21. Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3.
Milberg P; Pott C; Fink M; Frommeyer G; Matsuda T; Baba A; Osada N; Breithardt G; Noble D; Eckardt L
Heart Rhythm; 2008 Oct; 5(10):1444-52. PubMed ID: 18929333
[TBL] [Abstract][Full Text] [Related]
22. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsades de Pointes in models of acquired and congenital long QT syndrome.
Shimizu W; McMahon B; Antzelevitch C
J Cardiovasc Electrophysiol; 1999 Feb; 10(2):154-64. PubMed ID: 10090218
[TBL] [Abstract][Full Text] [Related]
23. [Sotalol and torsades de pointes ventricular tachycardia].
Petersen HH; Sandøe E
Ugeskr Laeger; 1996 May; 158(19):2711-6. PubMed ID: 8744073
[TBL] [Abstract][Full Text] [Related]
24. Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart.
Guérard NC; Traebert M; Suter W; Dumotier BM
J Pharmacol Toxicol Methods; 2008; 58(1):32-40. PubMed ID: 18582585
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.
Zabel M; Hohnloser SH; Behrens S; Li YG; Woosley RL; Franz MR
J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1148-58. PubMed ID: 9363818
[TBL] [Abstract][Full Text] [Related]
26. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
[TBL] [Abstract][Full Text] [Related]
27. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block.
Vos MA; Verduyn SC; Gorgels AP; Lipcsei GC; Wellens HJ
Circulation; 1995 Feb; 91(3):864-72. PubMed ID: 7828315
[TBL] [Abstract][Full Text] [Related]
28. In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
Gallacher DJ; Van de Water A; van der Linde H; Hermans AN; Lu HR; Towart R; Volders PG
Cardiovasc Res; 2007 Nov; 76(2):247-56. PubMed ID: 17669388
[TBL] [Abstract][Full Text] [Related]
29. Calmodulin antagonist W-7 prevents sparfloxacin-induced early afterdepolarizations (EADs) in isolated rabbit purkinje fibers: importance of beat-to-beat instability of the repolarization.
Lu HR; Vlaminckx E; Van de Water A; Gallacher DJ
J Cardiovasc Electrophysiol; 2006 Apr; 17(4):415-22. PubMed ID: 16643366
[TBL] [Abstract][Full Text] [Related]
30. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Shah SA; Kluger J; White CM
Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential?
Carlsson L; Amos GJ; Andersson B; Drews L; Duker G; Wadstedt G
J Pharmacol Exp Ther; 1997 Jul; 282(1):220-7. PubMed ID: 9223557
[TBL] [Abstract][Full Text] [Related]
32. KN-93, A CaMKII inhibitor, suppresses ventricular arrhythmia induced by LQT2 without decreasing TDR.
Wang WL; Zhang SS; Deng J; Zhao JY; Zhao CQ; Lin L; Zhang CT; Lv JG
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):636-639. PubMed ID: 24142712
[TBL] [Abstract][Full Text] [Related]
33. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
Shimizu W; Antzelevitch C
Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
[TBL] [Abstract][Full Text] [Related]
34. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
Verduyn SC; Vos MA; van der Zande J; Kulcsàr A; Wellens HJ
J Am Coll Cardiol; 1997 Nov; 30(6):1575-84. PubMed ID: 9362418
[TBL] [Abstract][Full Text] [Related]
35. The mechanism of pause-induced torsade de pointes in long QT syndrome.
Liu J; Laurita KR
J Cardiovasc Electrophysiol; 2005 Sep; 16(9):981-7. PubMed ID: 16174020
[TBL] [Abstract][Full Text] [Related]
36. [Torsade de Pointes tachycardia during sotalol treatment of a patient with normal potassium levels].
Appel JM; Sigurd B
Ugeskr Laeger; 1996 Jul; 158(28):4093-4. PubMed ID: 8701528
[TBL] [Abstract][Full Text] [Related]
37. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo: torsades de pointes develops with halothane but not pentobarbital anesthesia.
Weissenburger J; Nesterenko VV; Antzelevitch C
J Cardiovasc Electrophysiol; 2000 Mar; 11(3):290-304. PubMed ID: 10749352
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological enhancement of cardiac gap junction coupling prevents arrhythmias in canine LQT2 model.
Quan XQ; Bai R; Lu JG; Patel C; Liu N; Ruan Y; Chen BD; Ruan L; Zhang CT
Cell Commun Adhes; 2009; 16(1-3):29-38. PubMed ID: 19629804
[TBL] [Abstract][Full Text] [Related]
39. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
Shimizu W; Antzelevitch C
J Electrocardiol; 1999; 32 Suppl():177-84. PubMed ID: 10688323
[TBL] [Abstract][Full Text] [Related]
40. Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.
Milberg P; Reinsch N; Wasmer K; Mönnig G; Stypmann J; Osada N; Breithardt G; Haverkamp W; Eckardt L
Cardiovasc Res; 2005 Feb; 65(2):397-404. PubMed ID: 15639478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
